
Stem cell-derived islet cell replacement therapy has the potential to effectively treat type 1 diabetes by restoring the body's ability to produce insulin, reducing severe hypoglycemic episodes and insulin dependence.


coremsg

In the latest update of Vertex's VX-880, three patients at high hypoglycemia risk achieved A1c < 7% with no severe hypoglycemia episodes and were insulin independent at 1 year.

Stem Cell–Derived Islets Continue to Show Benefit in T1D

stem-cell-derived-islet-transplants-show-promising-results-in-treating-severe-hypoglycemia-in-type-1-diabetes


Stem Cell-Derived Islet Transplants Show Promising Results in Treating Severe Hypoglycemia in Type 1 Diabetes
